Advanced ovarian cancer: 20 years of ovarian cancer treatment

被引：6
|
作者：
Poveda, A. [1 ]
Romero, I. [1 ]
机构：
[1] Fdn Inst Valenciano Oncol, Dept Gynecol Oncol, C Beltran Baguena 8, Valencia 46009, Spain
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
PEGYLATED LIPOSOMAL DOXORUBICIN; TREATMENT RESPONSE; MUTATIONS; OLAPARIB; BRCA1;
D O I：
10.1093/annonc/mdw081
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：72 / 73
页数：2
相关论文
共 50 条
  • [1] Treatment in advanced ovarian cancer
    Schoenlieb, C.
    Oncology Research and Treatment, 2015, 38 : 205 - 205
  • [2] Treatment of advanced ovarian cancer
    du Bois, A
    EUROPEAN JOURNAL OF CANCER, 2001, 37 : S1 - S7
  • [3] TREATMENT OF ADVANCED OVARIAN CANCER
    KOLSTAD, P
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1975, : 53 - 53
  • [4] TREATMENT OF ADVANCED OVARIAN-CANCER - 10 YEARS OF EXPERIENCE
    NEIJT, JP
    ANNALS OF ONCOLOGY, 1992, 3 (01) : 17 - 27
  • [5] Guideline for treatment of advanced ovarian cancer
    Votavová, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S23 - S23
  • [6] Surgical treatment in advanced ovarian cancer
    Kuhn, W
    du Bois, A
    Pfisterer, J
    GYNAKOLOGE, 2001, 34 (11): : 1050 - 1057
  • [7] Caelyx® in the treatment of advanced ovarian cancer
    Bauknecht, T
    ONKOLOGIE, 2000, 23 : 40 - 45
  • [8] Controversy in treatment of advanced ovarian cancer
    Scambia, Giovanni
    Salutari, Vanda
    Amadio, Giulia
    LANCET ONCOLOGY, 2013, 14 (10): : 920 - 921
  • [9] When advanced ovarian cancer is not ovarian cancer.
    Dood, Robert
    Fleming, Nicole D.
    Coleman, Robert L.
    Westin, Shannon Neville
    Sood, Anil
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Advanced ovarian cancer
    van der Burg M.E.L.
    Current Treatment Options in Oncology, 2001, 2 (2) : 109 - 118
12345